Concurrent Investment Advisors »

Oncolytics Biotech shares owned by Concurrent Investment Advisors

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Concurrent Investment Advisors from 13F filings

Historical chart of Concurrent Investment Advisors investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Concurrent Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Concurrent Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $12k 13k 0.95

More positions owned by Concurrent Investment Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Call Option (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation Call Option (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon Call Option (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom Call Option (AVGO)
Vanguard Index Fds Total Stk Mkt (VTI)
Micron Technology (MU)
Vanguard Index Fds Value Etf (VTV)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Concurrent Investment Advisors

Top funds holding Oncolytics Biotech

Marshall Wace
XTX Topco
Seeds Investor
International Assets Investment Management
Connective Capital Management
Goldman Sachs Group
Tocqueville Asset Management
Everhart Financial Group
Susquehanna International
PFG Investments
Hrt Financial
Invesco
Doliver Capital Advisors
LPL Financial
Franklin Resources

View all funds holding Oncolytics Biotech